Reliant Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
8,792
+8
+0.1% +$924 0.88% 25
2025
Q4
$925K Buy
8,784
+9
+0.1% +$845 0.73% 32
2025
Q3
$783K Buy
8,775
+11
+0.1% +$906 0.61% 41
2025
Q2
$694K Sell
8,764
-416
-5% -$33.1K 0.61% 39
2025
Q1
$824K Buy
9,180
+9
+0.1% +$840 0.84% 23
2024
Q4
$912K Buy
+9,171
New +$945K 0.81% 25

Other funds holding MRK

Reliant Investment Partners's MRK Position: Q1 2026 in Review

Reliant Investment Partners increased its Merck (MRK) stake by 0.09% in Q1 2026, buying an estimated $924 and bringing the position to 8,792 shares worth $1.06M. The position accounts for 0.88% of the portfolio, ranked #25.

Reliant Investment Partners first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Reliant Investment Partners held 8,792 shares of Merck worth $1.06M as of Q1 2026.
  • Reliant Investment Partners bought 8 Merck shares in Q1 2026, an estimated $924.
  • Merck made up 0.88% of Reliant Investment Partners's portfolio in Q1 2026, its #25 holding.
  • Reliant Investment Partners first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Reliant Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.